Bioinformatics core

Numerous publicly funded projects are generating a vast resource of sequencing, biomarker and other data relevant to Alzheimer's Disease (AD), including projects such as the AD sequencing project (ADSP), the Alzheimer’s disease Accelerating Medicines Partnership (AD-AMP) and the Alzheimer’s disease Neuroimaging Initiative (ADNI) funded by the NIA. We are systematically collecting and analyzing as many datasets as possible to perform state of-the-art analyses to identify putative causative variants and biomarkers for AD. Utilizing these datasets ensures that the animal modeling and preclinical testing approaches align closely with human AD.

AD Center Strategy